Recently, Tibet Duorui Pharmaceutical Co.
, Ltd.
issued an announcement
on the cancellation of its holding subsidiary.
According to the content of the announcement, in order to improve the company's asset management efficiency, optimize the organizational structure and reduce management costs, Tibet Duorui Pharmaceutical Co.
, Ltd.
recently cancelled its holding subsidiary, Gongan County Renkang Pharmaceutical Technology Co.
, Ltd.
It is understood that in order to reduce costs, Duorui Pharmaceutical has cancelled a wholly-owned subsidiary, Hubei Benyang Pharmaceutical Co.
, Ltd.
, in May this year.
In fact, in recent years, the pharmaceutical industry has introduced a series of policies such as consistency evaluation of generic drugs, centralized procurement, medical insurance fee control, and key monitoring of auxiliary drugs, which has led to the continuous squeeze of the profit margins of pharmaceutical companies, and the entire market reshuffle has begun to accelerate
.
In this context, in order to recover funds and reduce operating costs, in addition to deregistering subsidiaries, pharmaceutical companies sell "assets" everywhere
.
For example, on October 10, Ruixing Pharmaceutical issued an announcement that in order to reduce management costs and improve operational efficiency, the general manager made the "General Manager Decision" on August 15, 2022, deciding to cancel Foshan Ruixing Network Technology Co.
, Ltd.
, a wholly-owned subsidiary.
On September 30, Zima Gene issued an announcement that in order to reduce the company's management costs, the meeting deliberated and passed a proposal
to cancel its wholly-owned subsidiary, Anhui Zima Gene Pharmaceutical Co.
, Ltd.
On September 27, Zhenghe Pharmaceutical issued an announcement that in order to optimize the asset structure, reduce investment risks, and improve management and operation efficiency, Zhenghe Pharmaceutical Co.
, Ltd.
, a wholly-owned subsidiary, intends to cancel its wholly-owned subsidiary, Jilin Zhenghe Business Electronics Co.
, Ltd.
On September 22, Luoxin Pharmaceutical announced that it planned to transfer 70% of the equity of Modern Logistics to Shanghai Pharmaceutical Holdings
for 415 million yuan.
After the transfer, the company will only hold a 30% stake
in Modern Logistics.
On September 13, Shanghai Kaibao issued an announcement that the company intends to sell the shares of Shanghai Yizhong held by the company through centralized bidding or block trading within 6 months after the board of directors deliberates and passes, during the period permitted by laws and regulations, no more than 3% of the existing total share capital of Shanghai Yizhong (about 3.
174 million shares).
.
.
.
.
.
.
It is worth noting that in addition to domestic pharmaceutical companies, there are many
multinational pharmaceutical companies that have opened the "fire sale model".
As recently reported, Viatris is considering selling its European consumer health business, a deal that could reach 3 billion euros
.
On October 9, Bayer officially completed the sale of its Environmental Science Professional business to international private equity firm Cinven
.
At a time when the pharmaceutical market is affected by reform and the concentration is increasing, whether it is for the purpose of "returning blood", or for the purpose of gathering resources and focusing on the main business, this situation of "selling, selling and selling" will continue
in the future.
However, the sale of assets can only help pharmaceutical companies solve temporary problems, and the industry generally believes that in the current pharmaceutical environment, pharmaceutical companies need to focus on innovation and development and increase investment in research and development in order to enhance the competitiveness of enterprises and gain a foothold in the market
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
